Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
Dr. Pesek’s current research areas of interest are in food allergy, asthma, and eosinophilic gastrointestinal disorders. He is a sub-investigator in NIH funded research of novel food allergy treatments. He is a collaborator on several research studies with the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) whose aim is to improve the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations. Current studies include investigation of the natural history of eosinophilic gastritis, enteritis, and colitis as well as dietary management of children with eosinophilic esophagitis (EoE). Dr. Pesek is the Medical Director of Asthma for Arkansas Children’s. The asthma program aims to improve the health of all children in Arkansas with asthma through a partnership with primary care and specialty providers throughout the state as well as investigation of novel treatments for asthma.
All patient satisfaction surveys are submitted by verified patients and families of Arkansas Children's. The star rating is an average of all responses to the provider-related questions by an independent patient satisfaction company. Responses are measured on a scale of 1 to 5 with 5 being the best score. The comments listed reflect the positive experiences submitted by patients and families through the survey process. The comments are not endorsed by and do not necessarily reflect the views or Arkansas Children's.
Our primary care clinics provide services such as well-child visits (annual check-ups and child development milestones), immunizations, newborn care, common pediatric illnesses (sick visits), behavioral visits, and sports and school physicals. Call us today to schedule an appointment.
The COVID-19 vaccine is now available to teens in Arkansas 16 years and older. Dr. Jessica Snowden, chief of pediatric infectious disease at Arkansas Children’s was interviewed by KATV and addressed questions about the safety of the vaccine for the youth population.